India, Jan. 21 -- Vertigo and balance disorders impact nearly six crore people in India. These patients are often misdiagnosed or treated with symptom-suppressing medication rather than specific therapy for the underlying disease. Addressing this critical gap, Jaipur-based startup FutureCure Health Private Limited, a healthcare technology company focused on super-speciality care, has completed a Rs 104 crore funding round to expand access to the diagnosis and treatment of vertigo.
The investment was led by Carnelian Asset Management LLP, with participation from other marquee investors. The fundraising follows an earlier $4 million round in 2022 backed by Kotak Alternate Asset Management, RVCF Ventures, and Unicorn India Ventures.
Future...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.